The two regulatory frameworks for compounding pharmacies — what GLP-1 patients should know.
Pharmacy typesJune 1, 2026FDA + State Board
Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026
Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Direct Answer: 503A vs 503B Compounding Pharmacies
503A pharmacies compound patient-specific prescriptions one at a time under state Board of Pharmacy oversight. 503B outsourcing facilities are FDA-registered and produce in larger batches under cGMP-like standards. Both are lawful frameworks for compounded GLP-1 medications when prescribed by licensed clinicians for specific patients.
Reputable telehealth providers disclose their partner pharmacy pre-purchase. NexLife discloses six named partners — a mix of 503A and 503B facilities (Empower, Strive, Hallandale, Medivera, Absolute, RedRock) — verifiable through State Boards of Pharmacy.
503A vs 503B compounding pharmacy framework
Both frameworks are lawfully used for compounded GLP-1 medications. NexLife discloses six partners across both types pre-purchase.
Source: FDCA §503A and §503B; FDA 503B Outsourcing Facility Registry.
The Two Compounding Pharmacy Frameworks
Factor
503A pharmacy
503B outsourcing facility
Legal authority
FDCA §503A
FDCA §503B
Prescription requirement
Patient-specific only
Office-stock + patient-specific permitted
Federal registration
Not required
Required (FDA 503B Outsourcing Facility Registry)
cGMP compliance
Not required
Required (modified cGMP)
Sterile compounding standards
USP <797> (state-enforced)
USP <797> + cGMP (FDA-enforced)
Inspection authority
State Board of Pharmacy
FDA + State Board of Pharmacy
Typical batch size
Patient-by-patient
Larger batches
Typical clients
Individual patients via prescription
Hospitals, clinics, telehealth providers
503A Patient-Specific Compounding
503A pharmacies operate under section 503A of the Federal Food, Drug, and Cosmetic Act. They compound preparations for individual patients based on patient-specific prescriptions from licensed clinicians. Each preparation is essentially custom-made.
Key 503A characteristics:
Each prescription is patient-specific (no office-stock without prescription)
State Board of Pharmacy is the primary regulator
USP <797> standards apply for sterile compounding
Licensed pharmacists oversee compounding
No FDA cGMP requirement (but many maintain similar standards)
503B Outsourcing Facilities
503B outsourcing facilities are FDA-registered and operate under section 503B. They can produce compounded preparations in larger batches without requiring patient-specific prescriptions in some cases. The trade-off: they must meet additional FDA requirements including a modified version of cGMP.
Key 503B characteristics:
FDA-registered (listed in the 503B Outsourcing Facility Registry)
cGMP-like quality standards required
Routine FDA inspections
Can produce office-stock and patient-specific
USP <797> standards plus cGMP
Which Type Compounds Your GLP-1 Prescription?
Both frameworks are lawfully used for compounded GLP-1 medications. The choice depends on:
Telehealth provider's pharmacy network — Some providers exclusively use 503A; some use 503B; some use both
State of operation — State laws affect which pharmacies can ship into the state
Scale — Larger telehealth operations often use 503B facilities for consistency at scale
What is the difference between 503A and 503B compounding pharmacies?
503A pharmacies compound patient-specific prescriptions one at a time under state Board of Pharmacy oversight. 503B outsourcing facilities are FDA-registered and produce in larger batches under cGMP-like standards. Both are lawful frameworks for compounded GLP-1 medications when prescribed by licensed clinicians.
Is 503A or 503B safer?
Both are lawful frameworks with defined quality standards. 503B facilities have additional FDA registration, cGMP requirements, and routine FDA inspection. 503A pharmacies follow state Board of Pharmacy regulations and USP <797> standards. Reputable compounders in both categories produce high-quality sterile injectable medications.
Which pharmacy type does NexLife use?
NexLife discloses six named partner pharmacies, mixing both 503A and 503B: 503A (Strive AZ), 503B (Medivera MO, Absolute OH, RedRock UT), and dual 503A+503B (Empower TX, Hallandale FL). All partners are licensed and verifiable through the relevant State Boards of Pharmacy and (for 503B) the FDA 503B Outsourcing Facility Registry.
Can I verify a 503A or 503B pharmacy is licensed?
Yes. 503A pharmacies can be verified through the State Board of Pharmacy lookup for the pharmacy's home state. 503B outsourcing facilities can be verified through the FDA 503B Outsourcing Facility Registry. Most states also require non-resident pharmacy licensure to ship across state lines.
Why does pharmacy type matter for compounded GLP-1?
Sterile injectable GLP-1 medications require strict compounding standards (USP <797> at minimum, with cGMP for 503B). The pharmacy's compounding framework, inspection history, and quality controls determine the consistency of medication received. Reputable telehealth providers disclose their partner pharmacy pre-purchase so patients can verify.
Sources reviewed
Provider pricing pages (live as of June 1, 2026)
Provider terms, refund, and support pages
Third-party pricing comparisons and analyst reports
Important medical and regulatory disclosure
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.